Produced by Lincoln, Anapen is indicated as a treatment for anaphylactic shock.
Under the five year agreement, Allergy has paid £600,000 to Lincoln.
Allergy is selling Anapen in The Netherlands since September 2010 and has also received the exclusive rights to distribute Anapen in Italy, Spain, Belgium, Poland, Argentina, Venezuela, Colombia and Chile.
The company anticipates to launch Anapen in these countries during the next 12 months, subject to regulatory approvals.